Select a medication above to begin.
Winrevair (sotatercept-csrk)
sotatercept
Adult Dosing .
Dosage forms: INJ
Special Note
- [formulation clarification]
- Info: nonproprietary name = sotatercept-csrk
pulmonary arterial HTN
- [0.7 mg/kg/dose SC q3wk]
- Start: 0.3 mg/kg/dose SC x1; Info: hold tx for at least 3wk if Hgb incr. >2 g/dL from previous dose and >ULN, if Hgb incr. >4 g/dL from baseline, if Hgb incr. >2 g/dL above ULN, or if Plt <50,000; reinitiate tx at 0.3 mg/kg/dose SC x1 if tx delay >9wk
renal dosing
- [no adjustment]
- renal impairment: no adjustment
- HD/PD: no adjustment; no supplement
hepatic dosing
- [not defined]
Peds Dosing .
Peds dosing is currently unavailable or not applicable for this drug.
Contraindications / Cautions .
- hypersensitivity to drug or ingredient
- Plt <50,000
- bleeding, severe
- pregnancy
- avoid: breastfeeding during tx and x4mo after D/C
- caution: female pts of reproductive potential
Drug Interactions .
Overview
sotatercept
activin signaling inhibitor
- antiplatelet effects
- thrombogenic effects
Avoid/Use Alternative
- enoxaparin
- fondaparinux
- tranexamic acid
Monitor/Modify Tx
- abemaciclib
- abrocitinib
- acalabrutinib
- ado-trastuzumab emtansine
- afatinib
- aflibercept
- alteplase
- aminocaproic acid
- anacaulase topical
- anagrelide
- angiotensin II
- anthrax immune globulin
- anti-inhibitor coagulant complex
- antihemophilic factor (factor VIII)/von Willebrand factor complex
- antithrombin
- apixaban
- argatroban
- asciminib
- asparaginase
- aspirin
- atidarsagene autotemcel
- avapritinib
- avatrombopag
- axitinib
- baricitinib
- bazedoxifene
- bevacizumab
- binimetinib
- bivalirudin
- botulism immune globulin
- brentuximab vedotin
- brolucizumab
- bromelain
- bromfenac ophthalmic
- C1 esterase inhibitor
- cabazitaxel
- cabozantinib
- calaspargase
- cangrelor
- caplacizumab
- carfilzomib
- celecoxib
- chorionic gonadotropin
- cilostazol
- citalopram
- clopidogrel
- clozapine
- coagulation factor IX
- coagulation factor VIIa
- coagulation factor XIII A-subunit
- collagenase clostridium histolyticum
- concizumab
- cysteamine
- cytomegalovirus immune globulin
- dabigatran
- dalteparin
- danazol
- danshen
- darbepoetin alfa
- dasatinib
- deferasirox
- defibrotide
- deflazacort
- desogestrel (contraceptive)
- desvenlafaxine
- deuruxolitinib
- dexamethasone
- diclofenac
- diclofenac ophthalmic
- diclofenac topical
- dienogest (contraceptive)
- diflunisal
- dimethyl fumarate
- diosmin
- dipyridamole
- diroximel fumarate
- drospirenone (contraceptive)
- drospirenone (hormone replacement)
- duloxetine
- edoxaban
- eltrombopag
- encorafenib
- epirubicin
- epoetin alfa
- epoprostenol
- eptifibatide
- erlotinib
- escitalopram
- estetrol (contraceptive)
- estradiol (contraceptive)
- estradiol (hormone replacement)
- estrogens, conjugated (hormone replacement)
- estrogens, esterified (hormone replacement)
- ethanol
- ethinyl estradiol (contraceptive)
- ethinyl estradiol (hormone replacement)
- ethynodiol (contraceptive)
- etodolac
- etonogestrel (contraceptive)
- evening primrose oil
- everolimus
- factor XIII concentrate
- faricimab
- fedratinib
- fenofibrate
- fenofibric acid
- fenoprofen
- fenugreek
- fitusiran
- fluoxetine
- flurbiprofen
- flurbiprofen ophthalmic
- fluvoxamine
- follitropin
- fruquintinib
- garlic
- gefitinib
- gemtuzumab ozogamicin
- ginkgo
- heparin
- hepatitis B immune globulin
- hydrocortisone
- ibrutinib
- ibuprofen
- ibuprofen lysine
- icosapent ethyl
- iloprost inhaled
- imatinib
- immune globulin
- indomethacin
- iohexol
- iomeprol
- iopamidol
- ketoprofen
- ketorolac
- ketorolac ophthalmic
- lazertinib
- lenalidomide
- lenvatinib
- levomilnacipran
- levonorgestrel (contraceptive)
- levonorgestrel (hormone replacement)
- lifileucel
- luspatercept
- lusutrombopag
- magnesium salicylate
- meclofenamate
- medroxyprogesterone (contraceptive)
- medroxyprogesterone (hormone replacement)
- mefenamic acid
- megestrol
- meloxicam
- menotropins
- methotrexate
- methoxy polyethylene glycol-epoetin beta
- methyl salicylate topical
- methyltestosterone
- milnacipran
- mitotane
- momelotinib
- monomethyl fumarate
- mycophenolate mofetil
- mycophenolic acid
- nabumetone
- naproxen
- nattokinase
- necitumumab
- nepafenac ophthalmic
- niacin (vitamin B3)
- nilotinib
- nintedanib
- norelgestromin (contraceptive)
- norethindrone (contraceptive)
- norethindrone acetate (hormone replacement)
- norgestimate (contraceptive)
- norgestimate (hormone replacement)
- norgestrel (contraceptive)
- nusinersen
- olaparib
- omega-3-acid
- ospemifene
- oxaliplatin
- oxaprozin
- pacritinib
- paroxetine
- pazopanib
- pegaspargase
- penicillin G
- pentosan polysulfate sodium
- pentoxifylline
- piperacillin
- piroxicam
- pirtobrutinib
- plasminogen, human
- pomalidomide
- ponatinib
- porfimer
- pralsetinib
- prasugrel
- progesterone (hormone replacement)
- progesterone vaginal (hormone replacement)
- prothrombin complex concentrate (human)
- raloxifene
- ramucirumab
- ranibizumab
- regorafenib
- resveratrol
- reteplase
- Rho(D) immune globulin
- ritlecitinib
- rivaroxaban
- romiplostim
- ruxolitinib
- ruxolitinib topical
- salsalate
- saw palmetto
- segesterone (contraceptive)
- selpercatinib
- selumetinib
- sertraline
- sipuleucel-T
- sirolimus albumin-bound
- sodium tetradecyl sulfate
- sorafenib
- sulindac
- sunitinib
- tamoxifen
- tenecteplase
- testosterone
- thalidomide
- ticagrelor
- tipranavir
- tirofiban
- tisotumab vedotin
- tivozanib
- tofacitinib
- tolmetin
- toremifene
- tovorafenib
- trametinib
- trazodone
- treprostinil
- tretinoin
- upadacitinib
- vaccinia immune globulin
- vadadustat
- valoctocogene roxaparvovec
- valproic acid
- vamorolone
- vandetanib
- varicella zoster immune globulin
- venlafaxine
- vilazodone
- vinpocetine
- von Willebrand factor
- vorapaxar
- vorinostat
- vortioxetine
- warfarin
- willow bark
- zanubrutinib
- ziv-aflibercept
Adverse Reactions .
Serious Reactions
- erythrocytosis
- thrombocytopenia, severe
- bleeding, severe
- impaired fertility (animal studies)
Common Reactions
- Hgb incr.
- Plt decr.
- headache
- epistaxis
- rash
- telangiectasia
- diarrhea
- dizziness
- erythema
- thrombocytopenia, severe
- bleeding, severe
Safety/Monitoring .
Monitoring Parameters
pregnancy test at baseline; Hgb, Plt at baseline, before each dose for 1st 5 doses or longer if unstable levels, then periodically and before each tx reinitiation
Pregnancy/Lactation .
Pregnancy
Clinical Summary
avoid use during pregnancy; no human data available; risk of embryo-fetal death, decr. fetal birth weight, and delayed ossification based on animal data at 0.6x and 4x MRHD
Pregnancy Reporting
report any suspected fetal exposure to Merck Sharp & Dohme, LLC adverse event reporting line at 1-877-888-4231
Individuals of Reproductive Potential
avoid pregnancy by using effective contraception during tx and for at least 4mo after D/C in female pts
Lactation
Clinical Summary
avoid breastfeeding during tx and x4mo after D/C; no human data to assess risk of infant harm or effects on milk production
Pharmacology .
Metabolism: catabolism; CYP450: unknown
Excretion: unknown; Half-life: 24 days
Subclass: Pulmonary Arterial Hypertension (PAH)
Mechanism of Action
binds to activin A and other TGF-b superfamily ligands, inhibiting activin signaling and modulating vascular proliferation
Formulary .
No Formulary Selected
Join Now to View Patient Handouts!
Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.
Current Members: Sign In.
Pill Pictures
Join Now to View Pill Pictures!
Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.
Current Members: Sign In.